Aptiom
Payments companies reported to CMS as associated with Aptiom. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Aptiom, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Aptiom
These are the largest totals companies reported as associated with Aptiom. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Selim Benbadis | Tampa, FL | Neurology (Psychiatry & Neurology) | $20,970.22 |
| Jason Bisping | Columbus, OH | Epilepsy | $16,846.21 |
| Amit Verma | Houston, TX | Sleep Medicine (Psychiatry & Neurology) | $14,813.48 |
| John Stern | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $6,622.05 |
| James Valeriano | Pittsburgh, PA | Neurology (Psychiatry & Neurology) | $5,854.63 |
| Idan Sharon | Brooklyn, NY | $5,130.92 | |
| Michael Smith | Fort Myers, FL | Neurology (Psychiatry & Neurology) | $1,118.16 |
| Randi Baculi | Dallas, TX | Neurology (Psychiatry & Neurology) | $1,081.15 |
| Raafat Iskander | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $929.80 |
| Munther Hijazin | Downey, CA | Neurology (Psychiatry & Neurology) | $907.78 |
Prescribed Aptiom?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.